loading

60 Degrees Pharmaceuticals Inc Borsa (SXTP) Ultime notizie

pulisher
Feb 11, 2025

60 Degrees Gets FDA Clearance to Import Antimalarial From Australia to Ensure Supply Continuity - Marketscreener.com

Feb 11, 2025
pulisher
Feb 11, 2025

Sixty Degrees Pharmaceuticals to Ensure Continuity of Tafenoquine Supply in U.S. by Importing Limited Quantity of KODATEF® - The Manila Times

Feb 11, 2025
pulisher
Feb 11, 2025

Sixty Degrees Pharmaceuticals to Ensure Continuity of - GlobeNewswire

Feb 11, 2025
pulisher
Feb 11, 2025

Malaria Drug Shortage Averted: FDA Green-Lights Australian Import for Critical U.S. Supply - StockTitan

Feb 11, 2025
pulisher
Feb 11, 2025

60 Degrees Pharmaceuticals Inc’s latest rating changes from various analysts - Knox Daily

Feb 11, 2025
pulisher
Feb 10, 2025

Bioceres Crop Solutions Corp (BIOX) Becoming More Attractive for Investors - Knox Daily

Feb 10, 2025
pulisher
Feb 10, 2025

Balance Sheet Insights: 60 Degrees Pharmaceuticals Inc (SXTP)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex

Feb 10, 2025
pulisher
Feb 09, 2025

Insiders Give Up US$71k As 60 Degrees Pharmaceuticals Stock Drops To US$0.55 - Simply Wall St

Feb 09, 2025
pulisher
Feb 07, 2025

60 Degrees Pharmaceuticals Inc [SXTP] Records 200-Day SMA of $1.8142 - Knox Daily

Feb 07, 2025
pulisher
Feb 06, 2025

60 Degrees Pharmaceuticals, Inc. Closes Registered Direct Offering and Concurrent Private Placement Raising Approximately $1.075 Million - Nasdaq

Feb 06, 2025
pulisher
Feb 06, 2025

Pharmaceutical Funding Alert: 60 Degrees Secures Fresh Capital Through Strategic Share Offering - StockTitan

Feb 06, 2025
pulisher
Feb 06, 2025

Form 424B5 60 DEGREES PHARMACEUTICA - StreetInsider.com

Feb 06, 2025
pulisher
Feb 06, 2025

How does 60 Degrees Pharmaceuticals Inc (SXTP) change from a tortoise to a hare? - SETE News

Feb 06, 2025
pulisher
Feb 05, 2025

60 Degrees Pharma Announces $1.075 Million Registered Direct Offering - citybiz

Feb 05, 2025
pulisher
Feb 05, 2025

60 Degrees Pharmaceuticals Secures $1.1 Mln In Registered Direct Offering - Nasdaq

Feb 05, 2025
pulisher
Feb 05, 2025

60 Degrees Pharmaceuticals, Inc. Announces $1.075 Million Registered Direct Offering and Concurrent Private Placement of Common Stock and Warrants - Nasdaq

Feb 05, 2025
pulisher
Feb 05, 2025

60 Degrees Pharma Announces $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewswire

Feb 05, 2025
pulisher
Feb 05, 2025

Pharma Stock Alert: SXTP Secures Fresh Capital Through Strategic Share Offering at $0.715 - StockTitan

Feb 05, 2025
pulisher
Feb 04, 2025

Weiss Ratings Reiterates Sell (E+) Rating for 60 Degrees Pharmaceuticals (NASDAQ:SXTP) - Defense World

Feb 04, 2025
pulisher
Feb 01, 2025

SXTP stock touches 52-week low at $0.7 amid market challenges - MSN

Feb 01, 2025
pulisher
Jan 30, 2025

60 Degrees Pharmaceuticals, Inc. Closes Registered Direct Offering and Concurrent Private Placement Raising Approximately $1.043 Million - Nasdaq

Jan 30, 2025
pulisher
Jan 30, 2025

60 Degrees Pharma Announces Closing of $1.043 Million - GlobeNewswire

Jan 30, 2025
pulisher
Jan 30, 2025

60 Degrees Pharma Secures Fresh Capital: Inside the $1M Financing Deal That's Turning Heads - StockTitan

Jan 30, 2025
pulisher
Jan 29, 2025

60 Degrees Pharmaceuticals announces stock and warrant sale - MSN

Jan 29, 2025
pulisher
Jan 29, 2025

US Stocks Mixed; General Dynamics Earnings Top Views - Benzinga

Jan 29, 2025
pulisher
Jan 29, 2025

60 Degrees Pharma Announces $1.043 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - The Manila Times

Jan 29, 2025
pulisher
Jan 29, 2025

Pharma Company's $1M Cash Injection Comes with Hidden UpsideComplete Analysis - StockTitan

Jan 29, 2025
pulisher
Jan 29, 2025

US Futures Point To Cautious Start As Investors Await Fed's Rate Decision: Tesla, Microsoft, Meta Among Stocks In Focus Ahead Of Earnings - Benzinga

Jan 29, 2025
pulisher
Jan 29, 2025

60 Degrees Pharmaceuticals obtains IRB approval for chronic babesiosis therapy trial - Yahoo! Voices

Jan 29, 2025
pulisher
Jan 29, 2025

Why F5 Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket - Benzinga

Jan 29, 2025
pulisher
Jan 28, 2025

60 Degrees Pharmaceuticals Gets Investigational Review Board Approval for Babesiosis Phase 2 Study - Marketscreener.com

Jan 28, 2025
pulisher
Jan 28, 2025

60 Degrees Pharmaceuticals, Inc. Announces the Approval of an Investigational Review Board Commissioned Phase II Clinical Study - Marketscreener.com

Jan 28, 2025
pulisher
Jan 28, 2025

60 Degrees Pharma Announces IRB Approval of Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis - GlobeNewswire

Jan 28, 2025
pulisher
Jan 28, 2025

Revolutionary Tick-Borne Disease Treatment Gets Green Light: 400,000 Patients Await New Hope - StockTitan

Jan 28, 2025
pulisher
Jan 21, 2025

Titan Pharma (NASDAQ:TTNP) Stock Quotes, Forecast and News Summary - Benzinga

Jan 21, 2025
pulisher
Jan 20, 2025

Palatin Technologies Inc (AMEX: PTN) Analysts Expect It Could Climb 93.76% From Current Levels. - Stocks Register

Jan 20, 2025
pulisher
Jan 20, 2025

60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) Jumps 0.32 Percent In Recent Trading, What Questions Do You Have? – Stocks Register - Stocks Register

Jan 20, 2025
pulisher
Jan 18, 2025

Corn and Brent Crude calendar spread - The Globe and Mail

Jan 18, 2025
pulisher
Jan 15, 2025

60 Degrees Pharmaceuticals Inc. (SXTP) Reports Q3 Loss, Misses Revenue Estimates - MSN

Jan 15, 2025
pulisher
Jan 14, 2025

No Bull | The Five Spot - The Globe and Mail

Jan 14, 2025
pulisher
Jan 13, 2025

Pre-market Movers: SAGE, ITCI, GCTK, MRNA... - RTTNews

Jan 13, 2025
pulisher
Jan 12, 2025

60 Degrees Pharmaceuticals (NASDAQ:SXTP) Earns Neutral Rating from HC Wainwright - Defense World

Jan 12, 2025
pulisher
Jan 12, 2025

Reviva Pharmaceuticals (NASDAQ:RVPH) Raised to “Strong-Buy” at Roth Capital - Defense World

Jan 12, 2025
pulisher
Jan 12, 2025

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives $57.10 Consensus Target Price from Brokerages - Defense World

Jan 12, 2025
pulisher
Jan 11, 2025

60 Degrees Pharmaceuticals Enrolls First Patient in Expanded Access Clinical Study for Babesiosis Treatment - Defense World

Jan 11, 2025
pulisher
Jan 09, 2025

60 Degrees Pharmaceuticals enrolls first patient in tafenoquine study - Yahoo Finance

Jan 09, 2025
pulisher
Jan 09, 2025

Barclays PLC Has $109,000 Stock Holdings in DLH Holdings Corp. (NASDAQ:DLHC) - Defense World

Jan 09, 2025
pulisher
Jan 08, 2025

SXTP60 Degrees Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan

Jan 08, 2025
pulisher
Jan 08, 2025

60 Degrees Pharmaceuticals Enrolls First Patient in - GlobeNewswire

Jan 08, 2025
pulisher
Jan 08, 2025

60 Degrees Pharma Launches Breakthrough Study for Stubborn Tick Disease Treatment After 80% Success - StockTitan

Jan 08, 2025
pulisher
Jan 05, 2025

🚀 Wall Street Radar: Stocks to Watch Next Week - substack.com

Jan 05, 2025
pulisher
Jan 03, 2025

Deal Watch: Regeneron Quietly Acquires UK Ophthalmology Firm Oxular - News & Insights

Jan 03, 2025
pulisher
Dec 31, 2024

Wayfair Inc (W-N) QuotePress Release - The Globe and Mail

Dec 31, 2024
pulisher
Dec 30, 2024

Parkinson's Treatment Advancements: Clinical Trials Begin for Potential New Therapy - Streetwise Reports

Dec 30, 2024
pulisher
Dec 26, 2024

4 of Wall Street's Most Prominent Artificial Intelligence (AI) Stocks Have Made a Shocking $1.23 Trillion Investment - The Globe and Mail

Dec 26, 2024
pulisher
Dec 25, 2024

Wainwright maintains neutral on SXTP stock after patent deal By Investing.com - Investing.com Australia

Dec 25, 2024
$79.31
price up icon 0.81%
$21.37
price down icon 2.06%
$370.58
price up icon 0.04%
$4.94
price up icon 7.39%
biotechnology ONC
$230.86
price up icon 2.38%
$119.83
price down icon 2.40%
Capitalizzazione:     |  Volume (24 ore):